Evidence that TGF-β should be a therapeutic target in diabetic nephropathy
- 1 October 1998
- journal article
- Published by Elsevier in Kidney International
- Vol. 54 (4), 1390-1391
- https://doi.org/10.1046/j.1523-1755.1998.00127.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Renal expression of transforming growth factor-β inducible gene-h3 (βig-h3) in normal and diabetic ratsKidney International, 1998
- Interactions of Transforming Growth Factor-β and Angiotensin II in Renal FibrosisHypertension, 1998
- Increased Renal Production of Transforming Growth Factor-β1 in Patients with Type II DiabetesDiabetes, 1997
- Transforming Growth Factor β in Diabetic NephropathyDiabetes/Metabolism Research and Reviews, 1996
- Neutralization of TGF-β by Anti-TGF-β Antibody Attenuates Kidney Hypertrophy and the Enhanced Extracellular Matrix Gene Expression in STZ-Induced Diabetic MiceDiabetes, 1996
- Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitusKidney International, 1996
- Hyperglycemia and Diabetic Kidney Disease: The Case for Transforming Growth Factor–β as a Key MediatorDiabetes, 1995
- Transforming Growth Factor β in Tissue FibrosisNew England Journal of Medicine, 1994
- Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.Proceedings of the National Academy of Sciences, 1993